Jae Hwan Jung

Title: Jae Hwan Jung: Innovating Targeted Drug Delivery Methods

Introduction

Jae Hwan Jung is an accomplished inventor and researcher based in Atlanta, Georgia. With a focus on innovative medical technologies, he has made significant contributions to the field of drug delivery systems. His expertise has paved the way for new methods to administer therapeutic formulations effectively.

Latest Patents

Jae Hwan Jung holds a patent for "Targeted drug delivery methods using a microneedle." This invention outlines methods for administering formulations to the suprachoroidal space of the eye, allowing targeted delivery to specific sites within the eye. Notably, his technique involves using a pushing formulation that expands due to physiochemical cues or utilizing an electric field to influence the movement of the formulation within the suprachoroidal space. These advancements represent a significant leap in ocular therapeutic delivery.

Career Highlights

Jae Hwan Jung's professional journey includes his current affiliation with the Georgia Tech Research Corporation, where he leverages his knowledge to push the boundaries of medical technology. His work not only enhances the understanding of drug delivery mechanisms but also aims to improve patient outcomes through innovative solutions.

Collaborations

Throughout his career, Jae Hwan Jung has collaborated with esteemed colleague Mark R. Prausnitz. Together, they have combined their expertise to explore novel methods in targeted drug delivery, fostering a productive partnership that enhances their research's impact and applicability in real-world medical treatments.

Conclusion

Jae Hwan Jung stands out as a noteworthy inventor in the medical field, particularly in targeted drug delivery. His patented methodologies and collaborations reflect a commitment to improving therapeutic strategies. As research continues to develop, his contributions are likely to play a crucial role in the future of ocular medicine.